nitrendipine has been researched along with Osteosarcoma in 1 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This hypothesis was tested in the osteogenic sarcoma cell line UMR 106-01." | 1.28 | Parathyroid hormone-related peptide transiently increases cytosolic calcium in osteoblast-like cells: comparison with parathyroid hormone. ( Avioli, LV; Civitelli, R; Fausto, A; Gunsten, SL; Hruska, KA; Martin, TJ, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Civitelli, R | 1 |
| Martin, TJ | 1 |
| Fausto, A | 1 |
| Gunsten, SL | 1 |
| Hruska, KA | 1 |
| Avioli, LV | 1 |
1 other study available for nitrendipine and Osteosarcoma
| Article | Year |
|---|---|
Parathyroid hormone-related peptide transiently increases cytosolic calcium in osteoblast-like cells: comparison with parathyroid hormone.
Topics: Animals; Calcium; Cell Line; Cytosol; Diltiazem; Egtazic Acid; Fluorescent Dyes; Indoles; Kinetics; | 1989 |